Publications
May 11, 2021

Rigorous Assessment of Off-Target Editing by CRISPR/Cas9 in VOR33, an Engineered Hematopoietic Stem Cell Transplant for the Treatment of Acute Myeloid Leukemia

Platform, Trem-cel
Presented by: Genome Engineering Team– Vor Bio

ASGCT – 2021 – Poster Presentation 858